Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV- 2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial (oct, 2022)

被引：0
|
作者：
Khoo, S. H.
FitzGerald, R.
Saunders, G.
机构：
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E1 / E1
页数：1
相关论文
共 50 条
  • [41] The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD
    Singh, Dave
    Beier, Jutta
    Astbury, Carol
    Belvisi, Maria G.
    Da Silva, Carla A.
    Jauhiainen, Alexandra
    Jimenez, Eulalia
    Lei, Alejhandra
    Necander, Sofia
    Smith, Jaclyn A.
    Hamren, Ulrika Wahlby
    Xin, Wenjing
    Psallidas, Ioannis
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (04)
  • [42] Zilucoplan in immune-mediated necrotising myopathy : a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
    Mammen, Andrew L.
    Amato, Anthony A.
    Dimachkie, Mazen M.
    Chinoy, Hector
    Hussain, Yessar
    Lilleker, James B.
    Pinal-Fernandez, Iago
    Allenbach, Yves
    Boroojerdi, Babak
    Vanderkelen, Mark
    Delicha, Eumorphia Maria
    Koendgen, Harold
    Farzaneh-Far, Ramin
    Duda, Petra W.
    Sayegh, Camil
    Benveniste, Olivier
    LANCET RHEUMATOLOGY, 2023, 5 (02) : E67 - E76
  • [43] Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial
    Lunzer, R.
    JOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN, 2016, 23 (02): : 60 - 60
  • [44] A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults
    Luo, Deyan
    Pan, Hongxing
    He, Peng
    Yang, Xiaolan
    Li, Tao
    Ning, Nianzhi
    Fang, Xin
    Yu, Wenjing
    Wei, Mingwei
    Gao, Hui
    Wang, Xin
    Gu, Hongjing
    Mei, Maodong
    Li, Xinwang
    Zhang, Liangyan
    Li, Deyu
    Gao, Chunrun
    Gao, Jinbang
    Fei, Guoqiang
    Li, Ying
    Yang, Yuguo
    Xu, Yi
    Wei, Wenjin
    Sun, Yansong
    Zhu, Fengcai
    Hu, Zhongyu
    Wang, Hui
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (09):
  • [45] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIAL Response
    Holmes, Clive
    NEUROLOGY, 2015, 85 (23) : 2084 - 2084
  • [46] Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
    Di Rocco, Maja
    Forleo-Neto, Eduardo
    Pignolo, Robert J.
    Keen, Richard
    Orcel, Philippe
    Funck-Brentano, Thomas
    Roux, Christian
    Kolta, Sami
    Madeo, Annalisa
    Bubbear, Judith S.
    Tabarkiewicz, Jacek
    Szczepanek, Malgorzata
    Bachiller-Corral, Javier
    Cheung, Angela M.
    Dahir, Kathryn M.
    Botman, Esmee
    Raijmakers, Pieter G.
    Mukaddam, Mona Al
    Tile, Lianne
    Portal-Celhay, Cynthia
    Sarkar, Neena
    Hou, Peijie
    Musser, Bret J.
    Boyapati, Anita
    Mohammadi, Kusha
    Mellis, Scott J.
    Rankin, Andrew J.
    Economides, Aris N.
    Trotter, Dinko Gonzalez
    Herman, Gary A.
    O'Meara, Sarah J.
    Delgizzi, Richard
    Weinreich, David M.
    Yancopoulos, George D.
    Eekhoff, E. Marelise W.
    Kaplan, Frederick S.
    NATURE MEDICINE, 2023, 29 (10) : 2615 - +
  • [47] COLCHICINE FOR TREATMENT OF OSTEOARTHRITIS OF THE KNEE (CLOAK) - A PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Samuels, J.
    Bomfim, F.
    Toprover, M.
    Cohen, R.
    Davis, C.
    Krasnokutsky-Samuels, S.
    Pillinger, M. H.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S498 - S498
  • [48] Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial
    Kappos, Ludwig
    Arnold, Douglas L.
    Bar-Or, Amit
    Camm, John
    Derfuss, Tobias
    Kieseier, Bernd C.
    Sprenger, Till
    Greenough, Kristin
    Ni, Pingping
    Harada, Tomohiko
    LANCET NEUROLOGY, 2016, 15 (11) : 1148 - 1159
  • [49] Results of an interimanalysis of a phase 2, randomised, double-blind, placebo-controlled clinical trial of ZGN-1061 in patients with obesity and type 2 diabetes
    Kim, T.
    Zhuang, D.
    Hughes, T. E.
    Kim, D. D.
    Taylor, K.
    DIABETOLOGIA, 2018, 61 : S326 - S326
  • [50] Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial
    Pariser, David M.
    Bagel, Jerry
    Lebwohl, Mark
    Yosipovitch, Gil
    Chien, Elaine
    Spellman, Mary C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : 1314 - 1320
12345